AI assistant
CVS HEALTH Corp — Director's Dealing 2012
Feb 23, 2012
29875_dirs_2012-02-23_f25b35d2-60e7-450b-a349-b3d2db418969.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-02-22
Reporting Person: Bisaccia Lisa (SVP, Chief HR Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-22 | Common Stock | M | 11987 | $30.035 | Acquired | 15577 | Direct |
| 2012-02-22 | Common Stock | S | 11987 | $43.67 | Disposed | 3590 | Direct |
| 2012-02-22 | Common Stock | M | 10706 | $28.10 | Acquired | 14296 | Direct |
| 2012-02-22 | Common Stock | S | 10706 | $43.67 | Disposed | 3590 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-22 | Stock Option | $30.035 | M | 11987 | Disposed | 2013-04-03 | Common Stock (11987) | Direct |
| 2012-02-22 | Stock Option | $28.10 | M | 10706 | Disposed | 2016-04-01 | Common Stock (10706) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 26247.0004 | Direct |
| ESOP Common Stock | 541.7254 | Indirect |
| Stock Unit | 22568.0016 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (473.7955) | 473.7955 | Direct | |
| Stock Option | $20.21 | 2014-09-08 | Common Stock (0) | 0 | Direct |
| Stock Option | $34.42 | 2014-04-03 | Common Stock (11341) | 11341 | Direct |
| Stock Option | $41.17 | 2015-04-01 | Common Stock (13838) | 13838 | Direct |
| Stock Option | $36.23 | 2017-04-01 | Common Stock (45897) | 45897 | Direct |
| Stock Option | $34.96 | 2018-04-01 | Common Stock (48230) | 48230 | Direct |
Footnotes
F1: Represents weighted average sale price for this trading day. Multiple sales ere executed, with sales prices ranging between $43.66 and $43.69 per share.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $43.66 and $43.69 per share.
F3: Option became exercisable in three equal annual installments, commencing 4/3/2007.
F4: Option became exercisable in three equal annual installments, commencing 4/1/2010.
F5: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, as such time as has been elected by the reporting person.
F6: Remaining option became exercisable in three equal installments on 9/8/2007.
F7: Option became exercisable in three equal annual installments, commencing 4/2/2008
F8: Option became exercisable in three equal annual installments, commencing 4/1/2009.
F9: Option became exercisable in three equal annual installments, commencing 4/1/2011.
F10: Option becomes exercisable in four equal annual installments, commencing 4/1/2012.